![](/img/cover-not-exists.png)
Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913
Nakahara, Yoshiro, Shimokawa, Tsuneo, Misumi, Yuki, Nogami, Naoyuki, Shinkai, Tetsu, Seki, Nobuhiko, Hosomi, Yukio, Hida, Naoya, Okamoto, HiroakiJournal:
Investigational New Drugs
DOI:
10.1007/s10637-020-00985-4
Date:
August, 2020
File:
PDF, 262 KB
2020